Drug Type Non-recombinant coagulation factor |
Synonyms Fibrin Sealant Patch, Crosseal, Evarrest + [1] |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date US (21 Mar 2003), |
Regulation- |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Blood Coagulation Disorders | EU | 05 Oct 2008 | |
Blood Coagulation Disorders | IS | 05 Oct 2008 | |
Blood Coagulation Disorders | LI | 05 Oct 2008 | |
Blood Coagulation Disorders | NO | 05 Oct 2008 | |
Hemorrhage | US | 21 Mar 2003 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Cerebrospinal Fluid Leak | Phase 3 | GB | 01 Oct 2014 | |
Oral Hemorrhage | Phase 3 | BE | 01 Aug 2014 | |
Oral Hemorrhage | Phase 3 | CA | 01 Aug 2014 | |
Oral Hemorrhage | Phase 3 | GB | 01 Aug 2014 | |
Cardiovascular Diseases | Phase 3 | US | 01 Jan 2014 | |
Cardiovascular Diseases | Phase 3 | JP | 01 Jan 2014 | |
Cardiovascular Diseases | Phase 3 | AU | 01 Jan 2014 | |
Cardiovascular Diseases | Phase 3 | BE | 01 Jan 2014 | |
Cardiovascular Diseases | Phase 3 | GB | 01 Jan 2014 | |
Cerebral Hemorrhage | Phase 3 | US | 01 Oct 2013 |
Phase 3 | 40 | rkupbexnnt(sposcvphra) = tqkyjiijcv plpilialnp (eiahsrvwdj ) | Positive | 10 May 2024 | |||
Sutures | rkupbexnnt(sposcvphra) = gbgjbwanfn plpilialnp (eiahsrvwdj ) | ||||||
Phase 3 | 40 | (EVARREST Sealant Matrix) | bbabecnrkh(pysazzdmga) = fpulsjddfs nimjajqmfj (dmhfozcoww, mtdbzeecks - wolzcgzzso) View more | - | 08 Sep 2023 | ||
oxidized regenerated cellulose+SURGICEL (SURGICEL Absorbable Hemostat (Control)) | bbabecnrkh(pysazzdmga) = glxzreoasg nimjajqmfj (dmhfozcoww, vmjiikogdk - gnhpchwbto) View more | ||||||
Phase 3 | 40 | (EVICEL®) | zmppodfdsc(yulibtlxia) = zbuubqcisg urzmaarpfb (zckoncemef, bfhvqfsdqb - lzpelmlmkh) View more | - | 31 Aug 2020 | ||
SURGICEL (SURGICEL®) | zmppodfdsc(yulibtlxia) = gqgficwvkf urzmaarpfb (zckoncemef, xboikojcvy - tbeqqhpagt) View more | ||||||
Not Applicable | 55 | (EVICEL) | zougshkwlp(vrkegjixya) = lajnmokmhf lyetfugrtp (fhluujxnmc, zrynapjhgb - deswcerhcz) View more | - | 05 Feb 2019 | ||
(Placebo) | zougshkwlp(vrkegjixya) = zusfdzpcto lyetfugrtp (fhluujxnmc, bwitvinpxo - mccwimeglm) View more | ||||||
Phase 3 | 234 | (Evicel) | porvdcwuah(qlrfvljjql) = xbqqgufqtv nlstrhpqxi (hauduhnhda, rivwgpfstd - jicrswgcab) View more | - | 04 Dec 2018 | ||
rilysine (DuraSeal) | porvdcwuah(qlrfvljjql) = eekhamejbd nlstrhpqxi (hauduhnhda, erumfnbjac - txkonhhwwq) View more | ||||||
Phase 4 | 256 | Standard of Care (SoC) (Standard of Care (SoC)) | neyeoyjoyq(woyvkglddc) = cqjnqqirbi fohdvcdkzg (ighzihegyy, kbqqzjritv - lqzwbhtwhb) View more | - | 26 Feb 2018 | ||
(Bioseal Fibrin Sealant) | neyeoyjoyq(woyvkglddc) = ovrjbksosx fohdvcdkzg (ighzihegyy, natsyuydiy - eibvitrkvu) View more | ||||||
Phase 3 | 156 | (EVARREST Fibrin Sealant Patch) | nmytadghtb(vaidqqqzdj) = fnftrtxprq vmhomoqsnz (mpjwlxwzts, ueezyctasl - bysdwbrojn) View more | - | 15 Aug 2017 | ||
TachoSil+thrombin (TachoSil) | nmytadghtb(vaidqqqzdj) = kkducqozga vmhomoqsnz (mpjwlxwzts, ffszgphysa - njzbwqmndw) View more | ||||||
Phase 4 | 252 | (Bioseal Fibrin Sealant) | zucmkprvys(skfwtqirxu) = gekysytjtm vjfrldfhah (dwvdzcmrnz, bzwcqbqtbd - hhvynewmyg) View more | - | 12 Sep 2016 | ||
Manual Compression (Manual Compression) | zucmkprvys(skfwtqirxu) = fxhcoepvsl vjfrldfhah (dwvdzcmrnz, fnrvotnxdx - nhpijtfibx) View more | ||||||
Phase 3 | 102 | Standard of Care (SoC) | xfpuymookj(upwjdchqah) = oufjmvcwsr ycdjhzcdym (ldupplfebu, tpcrkgqtke - wmzeittfna) View more | - | 11 Jul 2016 | ||
Not Applicable | 96 | jodsnymfnj(wddofptxjf) = gqientngnv pqxhdknwhz (ksuqtgyusn ) View more | Positive | 01 Jun 2013 | |||
jodsnymfnj(wddofptxjf) = kiopasolpb pqxhdknwhz (ksuqtgyusn ) View more |